Abstract
The folate receptor (FR) is over-expressed in many human tumours and is being intensively studied also in the field of nanomedicine as a target to enhance the selectivity of drug delivery to cancer cells by using nanocarriers bearing folic acid (FA) on their surface. In this study we report the encapsulation of the photosensitizer (PS) meta-tetra(hydroxyphenyl)chlorin (m-THPC) in FA-targeted PEGylated liposomes used as a novel drug delivery system for photodynamic therapy (PDT) of cancer. Our in vitro investigations revealed that only a modest fraction of targeted liposomes were internalized by specific endocytosis in FR-positive KB cells. However, FA-liposomes doubled the uptake of the entrapped m-THPC with respect to un-targeted liposomes and enhanced the photo-induced cytotoxicity in KB cells. In contrast, in FRnegative A549 cells FA-targeted or un-targeted liposomes exhibited a very similar extent of internalization and as a consequence the same photo-killing efficiency.
Similar content being viewed by others
References
P. Agostinis, K. Berg, K. A. Cengel, T. H. Foster, A. W. Girotti, S. O. Gollnick, S. M. Hahn, M. R. Hamblin, A. Juzeniene, D. Kessel, M. Korbelik, J. Moan, P. Mroz, D. Nowis, J. Piette, B. C. Wilson, J. Golab, Photodynamic therapy of cancer: an update, CA Cancer J. Clin., 2011, 61, 250–281.
T. J. Dougherty, C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, Q. Peng, Photodynamic therapy, J. Natl. Cancer Inst., 1998, 90, 889–905.
S. B. Brown, E. A. Brown, I. Walker, The present and future role of photodynamic therapy in cancer treatment, Lancet Oncol., 2004, 5, 497–508.
M. R. Hamblin, T. Hasan, Photodynamic therapy: a new antimicrobial approach to infectious disease?, Photochem. Photobiol. Sci, 2004, 3, 436–450.
C. Hopper, Photodynamic therapy: a clinical reality in the treatment of cancer, Lancet Oncol., 2000, 1, 212–219.
C. Hadjur, N. Lange, J. Rebstein, P. Monnier, H. Van der Bergh, G. Wagnières, Spectroscopic studies of photobleaching and photoproduct formation of meta(tetrahydroxyphenyl)chlorin (mTHPC) used in photodynamic therapy. The production of singlet oxygen by mTHPC, J. Photochem. Photobiol., B, 1998, 45, 170–178.
D. Bechet, P. Couleaud, C. Frochot, M. L. Viriot, F. Guillemin, M. Barbery-Heyob, Nanoparticles as vehicles for delivery of photodynamic therapy agents, Trends Biotechnol., 2008, 26, 612–621.
A. Gupta, S. Wang, P. Pera, K. V. Rao, N. Patel, T. Y. Ohulchanskyy, J. Missert, J. Morgan, Y. E. Koo-Lee, R. Kopelman, R. K. Pandey, Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles, Nanomedicine, 2012, 8, 941–950.
P. Couleaud, V. Morosini, C. Frochot, S. Richeter, L. Raehmaand, J. O. Durand, Silica-based nanoparticles for photodynamic therapy applications, Nanoscale, 2010, 2, 1083–1095.
B. Klajnert, M. Rozanek, M. Bryszewska, Dendrimers in photodynamic therapy, Curr. Med. Chem., 2012, 19, 49032–412.
A. M. Bugaj, Targeted photodynamic therapy–a promising strategy of tumour treatment, Photochem. Photobiol. Sci., 2011, 10, 1097–1109.
D. S. Kohane, Microparticles and nanoparticles for drug delivery, Biotechnol. Bioeng., 2007, 96, 203–209.
E. M. Cohen, H. Ding, C. W. Kessinger, C. Khemtong, J. Gao, B. D. Sumer, Polymeric micelle nanoparticles for photodynamic treatment of head and neck cancer cells, Otolaryngol Head Neck Surg., 2010, 143, 109–115.
A. M. Master, M. E. Rodriguez, M. E. Kenney, N. L. Oleinick, A. S. Gupta, Delivery of the photosensitizer Pc4 in PEG-PCL micelles for in vitro PDT studies, J. Pharm. Sci., 2010, 99, 2386–2398.
S. J. Lee, K. Park, Y.-K. Oh, S.-H. Kwon, S. Her, I.-S. Kim, K. Choi, S. J. Lee, H. Kim, S. G. Lee, K. Kim, I. C. Kwon, Tumour specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumour-bearing mice, Biomaterials, 2009, 30, 2929–2939.
C. Kojima, Y. Toi, A. Harada, K. Kono, Preparation of poly(ethylene glycol)-attached dendrimers encapsulating photosensitizers for application to photodynamic therapy, Bioconjugate Chem., 2007, 18, 663–670.
I. Roy, T. Y. Ohulchanskyy, H. E. Pudavar, E. J. Bergey, A. R. Oseroff, J. Morgan, T. J. Dougherty, P. N. Prasad, Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy, J. Am. Chem. Soc., 2003, 125, 7860–7865.
Y. Cheng, A. C. Samia, J. D. Meyers, J. Panagopoulos, B. Frei, C. Burda, Highly efficient drug delivery with gold nanoparticles vectors for in vivo photodynamic therapy of cancer, J. Am. Chem. Soc., 2008, 130, 10634–10647.
M. J. Shieh, C. L. Peng, W. L. Chiang, C. H. Wang, C. Y. Hsu, S. J. Wang, P. S. Lai, Reduced skin photosensitivity with meta-tetra(hydroxyphenyl)chlorin-loaded micelles based on a poly(2-ethyl-2-oxazoline)-b-poly(d,l-lactide) diblock copolymer in vivo, Mol. Pharm., 2010, 7, 1244–1253.
W. J. Syu, H. P. Yu, C. Y. Hsu, Y. C. Rajan, Y. H. Hsu, Y. C. Chang, W. Y. Hsieh, C. H. Wang, P. S. Lai, Improved photodynamic cancer treatment by folate-conjugated polymeric micelles in a KB xenografted animal model, Small, 2012, 13, 2060–2069.
C. Compagnin, L. Baù, M. Mognato, L. Celotti, G. Miotto, M. Arduini, F. Moret, C. Fede, F. Selvestrel, I. M. Rio Echevarria, F. Mancin, E. Reddi, The cellular uptake of meta-tetra(hydroxyphenyl)chlorin entrapped in organically modified silica nanoparticles is mediated by serum proteins, Nanotechnology, 2009, 20, 345101.
M. Rojnik, P. Kocbek, F. Moret, C. Compagnin, L. Celotti, M. J. Bovis, J. H. Woodhams, A. J. MacRobert, D. Scheglmann, W. Helfrich, M. J. Verkaik, E. Papini, E. Reddi, J. Kos, In vitro and in vivo characterization of temoporfin-loaded PEGylated PLGA nanoparticles for use in photodynamic therapy, Nanomedicine, 2012, 7, 663–667.
B. Pegaz, E. Debefve, J. P. Ballini, G. Wagnieres, S. Spaniol, V. Albrecht, D. V. Scheglmann, N. E. Nifantiev, H. Van der Bergh, Y. N. Konan-Kouakou, Photothrombic activity of m-THPC-loaded liposomal formulations: pre-clinical assessment on chick chorioallantonic membrane model, Eur. J. Pharm. Sci., 2006, 28, 134–140.
J. Buchholz, B. Kaser-Hotz, T. Khan, B. C. Rohrer, K. Melzer, R. A. Schwendener, M. Roos, H. Walt, Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetra-hydroxyphenyl)chlorin in feline squamous cell carcinoma, Clin. Cancer Res., 2005, 11, 7538–7544.
H. P. Lasalle, D. Dumas, S. Gräfe, M. A. D’Hallewin, F. Guillemin, L. Bezdetnaya, Correlation between in vivo pharmakinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC, J. Controlled Release, 2009, 134, 118–124.
J. Kuntsche, I. Freislebena, F. Steinigerb, A. Fahra, Temoporfin-loaded liposomes: physicochemical characterization, Eur. J. Pharm. Sci., 2010, 40, 305–315.
A. L. Klibanov, K. Maruyama, V. P. Torchilin, L. Huang, Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes, FEBS Lett., 1990, 268, 235–237.
S. N. Dos, C. Allen, A. M. Doppen, M. Anantha, K. A. Cox, R. C. Gallagher, G. Karlsson, K. Edwards, G. Kenner, L. Samuels, M. S. Webb, M. B. Bally, Influence of poly(ethyleneglycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding, Biochim. Biophys. Acta, 2007, 1768, 1367–1377.
R. Tavano, D. Segat, E. Reddi, J. Kos, M. Rojnik, P. Kocbek, S. Iratni, D. Scheglmann, M. Colucci, I. M. Rio Echevarria, F. Selvestrel, F. Mancin, E. Papini, Procoagulant properties of bare and highly PEGylated vinyl-modified silica nanoparticles, Nanomedicine, 2010, 5, 881–896.
C. Compagnin, F. Moret, L. Celotti, G. Miotto, J. H. Woodhams, A. J. MacRobert, D. Scheglmann, S. Iratni, E. Reddi, Meta-tetra(hydroxyphenyl)chlorin-loaded liposomes sterically stabilised with poly(ethylene glycol) of different length and density: characterisation, in vitro cellular uptake and phototoxicity, Photochem. Photobiol. Sci., 2011, 10, 1751–1759.
M. J. Bovis, J. H. Woodhams, M. Loizidou, D. Scheglmann, S. G. Bown, A. J. MacRobert, Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy, J. Controlled Release, 2012, 30, 196–205.
N. Solban, I. Rizvi, T. Hasan, Targeted photodynamic therapy, Lasers Surg. Med., 2006, 38, 522–531.
F. Danhier, O. Feron, V. Préat, To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery, J. Controlled Release, 2010, 148, 135–146.
R. Schneider, F. Schmitt, C. Frochot, Y. Fort, N. Lourette, F. Guillemin, J.-F. Müller, M. Barberi-Heyob, Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy, Bioorg. Med. Chem., 2005, 13, 2799–2808.
J. Gravier, R. Schneider, C. Frochot, T. Bastogne, F. Schmitt, J. Didelon, F. Guillemin, M. Barberi-Heyob, Improvement of meta-tetra(hydroxyphenyl)chlorin-like photosensitizer selectivity with folate-based targeted delivery. Synthesis and in vivo delivery studies, J. Med. Chem., 2008, 51, 3867–3877.
C. Stefflova, H. Li, J. Chen, G. Zheng, Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent, Bioconjugate Chem., 2007, 18, 379–388.
M. M. Qualls, D. H. Thompson, Chloroaluminum phthalocyanine tetrasulfonate delivered via acid-labile diplasmenylcholine-folate liposome: intracellular localisation and synergistic phototoxicity, Int. J. Cancer, 2001, 93, 384–392.
S.-J. Yang, F.-H. Lin, K.-C. Tsai, M.-F. Wei, H.-M. Tsai, J.-M. Wong, M.-J. Shieh, Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells, Bioconjugate Chem., 2010, 21, 679–689.
V. Morosini, T. Bastogne, C. Frochot, R. Schneider, A. François, F. Guillemin, M. Barberi-Heyob, Quantum dot-folic acid conjugates as potential photosensitizers in photodynamic therapy of cancer, Photochem. Photobiol. Sci., 2011, 10, 842–851.
V. Reshetov, D. Kachatkou, T. Shmigol, V. Zorin, M. D’Hallewin, F. Guillemin, L. Bezdetnaya, Redistribution of meta-tetra(hydroxyphenyl)chlorin (m-THPC) from conventional and PEGylated liposomes to biological substrates, Photochem. Photobiol. Sci., 2011, 10, 911–919.
V. Reshetov, V. Zorin, A. Siupa, M. D’Hallewin, F. Giullemin, L. Bezdetnaya, Interaction of liposomal formulations of meta-tetra(hydroxyphenyl)chlorin (temoporfin) with serum proteins: protein binding and liposome destruction, Photochem. Photobiol., 2012, 88, 1256–1264.
S. Sasnouski, V. Zorin, I. Khludeyev, M. A. D’Hallewin, F. Guillemin, L. Bezdetnaya, Investigation of Foscan® interactions with plasma proteins, Biochim. Biophys. Acta, 2005, 1725, 394–402.
N. Parker, M. J. Turk, E. Westrick, J. D. Lewis, P. S. Low, C. P. Leamon, Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay, Anal. Biochem., 2005, 338, 284–293.
R. J. Lee, P. S. Low, Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis, J. Biol. Chem., 1994, 269, 3198–3204.
A. Yamada, Y. Taniguchi, T. Honda, Y. Hattori, Y. Maitani, Design of folate-linked liposomal doxorubicin to its antitumor effect in mice, Clin. Cancer Res., 2008, 14, 8161–8168.
A. Gabizon, A. T. Horowitz, D. Goren, D. Tzemach, F. Mandelbaum-Shavit, M. M. Qazen, S. Zalipsky, Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies, Bioconjugate Chem., 1999, 10, 289–298.
K. Kawano, Y. Maitani, Effects of polyethylene glycol spacer length and ligand density on folate receptor targeting of liposomal doxorubicin in vitro, J. Drug Deliv., 2011, 160967.
A. R. Hilgenbrink, P. S. Low, Folate receptor-mediated drug targeting: from therapeutics to diagnostics, J. Pharm. Sci., 2005, 94, 2135–2146.
M. García-Díaz, S. Nonell, A. Villanueva, J. C. Stockert, M. Cañete, A. Casadò, M. Mora, M. L. Sagristá, Do folate-receptor targeted liposomal photosensitizers enhance photodynamic therapy selectivity?, Biochim. Biophys. Acta, 2011, 1808, 1063–1071.
H. Shmeeda, Y. Amitay, J. Gorin, D. Tzemach, L. Mak, J. Ogorka, S. Kumar, J. A. Zhang, A. Gabizon, Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells, J. Controlled Release, 2010, 146, 76–83.
K. Watanabe, M. Kaneko, Y. Maitani, Functional coating of liposomes using a folate-polymer conjugate to target folate receptors, Int. J. Nanomed., 2012, 7, 3679–3688.
Author information
Authors and Affiliations
Corresponding author
Additional information
Electronic supplementary information (ESI) available. See DOI: 10.1039/c3pp25384h
Rights and permissions
About this article
Cite this article
Moret, F., Scheglmann, D. & Reddi, E. Folate-targeted PEGylated liposomes improve the selectivity of PDT with meta-tetra(hydroxyphenyl)-chlorin (m-THPC). Photochem Photobiol Sci 12, 823–834 (2013). https://doi.org/10.1039/c3pp25384h
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/c3pp25384h